Clark David A.
Chief Operating Officer at MD
- Sold, on record
- $9.3M
- Dollars the filings state
- Form 4 sales
- 18
- Latest Mar 1, 2019
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- MDPediatrix Medical Group, Inc.Chief Operating Officer
Sales by reason
0
Routine
5
Plan not stated
0
No plan
13
Unusual
Form 4 sales per year, every sale on record.
Timeline
- Mar 1, 2019Plan not stated
Sold 4.5% of their holdings
$212k6,452 shares at $32.90
- Jun 1, 2018Unusual
Sold 26.1% of their holdings
$524k11,607 shares at $45.15
- Jun 1, 2017Unusual
Sold 28.9% of their holdings
$561k10,202 shares at $54.99
- Jun 1, 2016Unusual
Sold 36.4% of their holdings
$777k11,470 shares at $67.78
- Jun 1, 2015Unusual
Sold 40.5% of their holdings
$1M14,654 shares at $70.48
- Jun 2, 2014Unusual
Sold 37.9% of their holdings
$925k16,230 shares at $57.00
- Jun 3, 2013Unusual
Sold 35.2% of their holdings
$787k8,645 shares at $91.01
- Nov 23, 2012Plan not stated
Sold 10.3% of their holdings
$156k2,019 shares at $77.16
- Nov 20, 2012Plan not stated
Sold 3.3% of their holdings
$46k600 shares at $77.10
- Nov 7, 2012Unusual
Sold 35.9% of their holdings
$762k9,881 shares at $77.12
10 of 18
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Dec 1, 2019 | Dec 3, 2019 | MD | Chief Operating Officer | Withheld for tax | 10,625 | $26.12 | $278k | 123,032 | SEC |
| Jun 1, 2019 | Jun 4, 2019 | MD | Chief Operating Officer | Withheld for tax | 3,307 | $24.66 | $82k | 133,657 | SEC |
| Mar 1, 2019 | Mar 1, 2019 | MD | Chief Operating Officer | Sold | 6,452 | $32.90 | $212k | 136,964 | SEC |
| Feb 12, 2019 | Feb 14, 2019 | MD | Chief Operating Officer | Awarded | 56,571 | 143,416 | SEC | ||
| Dec 1, 2018 | Dec 4, 2018 | MD | Pres. Mednax Natl Med Group | Awarded | 54,000 | 86,845 | SEC | ||
| Jun 1, 2018 | Jun 1, 2018 | MD | Pres. Mednax Natl Med Group | Sold | 11,607 | $45.15 | $524k | 32,845 | SEC |
| Mar 1, 2018 | Mar 2, 2018 | MD | Pres. Mednax Natl Med Group | Awarded | 19,352 | 44,452 | SEC | ||
| Dec 7, 2017 | Dec 8, 2017 | MD | Pres. Mednax Natl Med Group | AwardedRestricted Shares Units | 14,741 | 14,741 | SEC | ||
| Jun 1, 2017 | Jun 2, 2017 | MD | Pres. Mednax Natl Med Group | Sold | 10,202 | $54.99 | $561k | 25,100 | SEC |
| Jun 1, 2017 | Jun 2, 2017 | MD | Pres. Mednax Natl Med Group | Awarded | 15,277 | 35,302 | SEC | ||
| Jun 1, 2016 | Jun 3, 2016 | MD | President, Western Division | Sold | 11,470 | $67.78 | $777k | 20,025 | SEC |
| Jun 1, 2016 | Jun 3, 2016 | MD | President, Western Division | Awarded | 9,928 | 31,495 | SEC | ||
| Jun 1, 2015 | Jun 3, 2015 | MD | COO, Pediatrix Medical Group | Sold | 14,654 | $70.48 | $1M | 21,567 | SEC |
| Jun 1, 2015 | Jun 3, 2015 | MD | COO, Pediatrix Medical Group | Awarded | 9,615 | 36,221 | SEC | ||
| Jun 2, 2014 | Jun 3, 2014 | MD | COO, Pediatrix Medical Group | Sold | 16,230 | $57.00 | $925k | 26,606 | SEC |
| Jun 1, 2014 | Jun 3, 2014 | MD | COO, Pediatrix Medical Group | Awarded | 11,062 | 42,836 | SEC | ||
| Jun 3, 2013 | Jun 4, 2013 | MD | COO, Pediatrix Medical Group | Sold | 8,645 | $91.01 | $787k | 15,887 | SEC |
| Jun 1, 2013 | Jun 4, 2013 | MD | COO, Pediatrix Medical Group | Awarded | 6,867 | 24,532 | SEC | ||
| Nov 23, 2012 | Nov 26, 2012 | MD | COO, Pediatrix Division | Sold | 2,019 | $77.16 | $156k | 17,665 | SEC |
| Nov 23, 2012 | Nov 26, 2012 | MD | COO, Pediatrix Division | Exercised or settledStock Options (Right to Buy) | 2,019 | $57.09 | $115k | 0 | SEC |
| Nov 23, 2012 | Nov 26, 2012 | MD | COO, Pediatrix Division | Exercised options | 2,019 | $57.09 | $115k | 19,684 | SEC |
| Nov 20, 2012 | Nov 21, 2012 | MD | COO, Pediatrix Division | Sold | 600 | $77.10 | $46k | 17,665 | SEC |
| Nov 20, 2012 | Nov 21, 2012 | MD | COO, Pediatrix Division | Exercised or settledStock Options (Right to Buy) | 600 | $57.09 | $34k | 2,019 | SEC |
| Nov 20, 2012 | Nov 21, 2012 | MD | COO, Pediatrix Division | Exercised options | 600 | $57.09 | $34k | 18,265 | SEC |
| Nov 7, 2012 | Nov 9, 2012 | MD | COO, Pediatrix Division | Sold | 9,881 | $77.12 | $762k | 17,665 | SEC |
| Nov 7, 2012 | Nov 9, 2012 | MD | COO, Pediatrix Division | Exercised or settledStock Options (Right to Buy) | 9,881 | $57.09 | $564k | 2,619 | SEC |
| Nov 7, 2012 | Nov 9, 2012 | MD | COO, Pediatrix Division | Exercised options | 9,881 | $57.09 | $564k | 27,546 | SEC |
| Jun 1, 2012 | Jun 5, 2012 | MD | COO, Pediatrix Division | Sold | 9,152 | $59.89 | $548k | 17,665 | SEC |
| Jun 1, 2012 | Jun 5, 2012 | MD | COO, Pediatrix Division | Awarded | 9,582 | 26,817 | SEC | ||
| Feb 27, 2012 | Feb 28, 2012 | MD | COO / Pediatrix Division | Sold | 13,800 | $75.46 | $1M | 17,235 | SEC |
| Feb 27, 2012 | Feb 28, 2012 | MD | COO / Pediatrix Division | Exercised or settledStock Options (Right to Buy) | 13,800 | $55.43 | $765k | 0 | SEC |
| Feb 27, 2012 | Feb 28, 2012 | MD | COO / Pediatrix Division | Exercised options | 13,800 | $55.43 | $765k | 21,335 | SEC |
| Jun 2, 2011 | Jun 3, 2011 | MD | COO / Pediatrix Division | Sold | 8,188 | $73.62 | $603k | 17,235 | SEC |
| Jun 1, 2011 | Jun 3, 2011 | MD | COO / Pediatrix Division | Awarded | 7,895 | 25,423 | SEC | ||
| May 20, 2011 | May 23, 2011 | MD | COO / Pediatrix Division | Sold | 1,200 | $75.44 | $91k | 17,528 | SEC |
| May 20, 2011 | May 23, 2011 | MD | COO / Pediatrix Division | Exercised or settledEmployee Stock Options (Right to Buy) | 1,200 | $55.43 | $67k | 8,800 | SEC |
| May 20, 2011 | May 23, 2011 | MD | COO / Pediatrix Division | Exercised options | 1,200 | $55.43 | $67k | 18,728 | SEC |
| Dec 10, 2010 | Dec 10, 2010 | MD | COO / Pediatrix Division | Sold | 7,456 | $64.75 | $483k | 17,528 | SEC |
| Dec 10, 2010 | Dec 10, 2010 | MD | COO / Pediatrix Division | Exercised or settledStock Options | 7,456 | 0 | SEC | ||
| Dec 10, 2010 | Dec 10, 2010 | MD | COO / Pediatrix Division | Exercised options | 7,456 | $44.70 | $333k | 24,984 | SEC |
| Dec 2, 2010 | Dec 3, 2010 | MD | COO / Pediatrix Division | Sold | 2,960 | $64.72 | $192k | 17,528 | SEC |
| Dec 2, 2010 | Dec 3, 2010 | MD | COO / Pediatrix Division | Exercised or settledStock Options | 2,960 | 7,456 | SEC | ||
| Dec 2, 2010 | Dec 3, 2010 | MD | COO / Pediatrix Division | Exercised options | 2,960 | $44.70 | $132k | 20,488 | SEC |
| Jun 1, 2010 | Jun 3, 2010 | MD | COO / Pediatrix Division | Sold | 6,755 | $55.95 | $378k | 9,067 | SEC |
| Jun 1, 2010 | Jun 3, 2010 | MD | COO / Pediatrix Division | Awarded | 8,461 | 17,528 | SEC | ||
| Jun 1, 2009 | Jun 2, 2009 | MD | COO / Pediatrix Division | Sold | 4,792 | $40.51 | $194k | 4,722 | SEC |
| Jun 1, 2009 | Jun 2, 2009 | MD | COO / Pediatrix Division | Awarded | 11,100 | 15,822 | SEC |
Sales and notices (18)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 1, 2019 | Mar 1, 2019 | MD | Chief Operating Officer | Form 4 sale | 6,452 | $212k | 4.5% | Plan not stated | SEC |
| Jun 1, 2018 | Jun 1, 2018 | MD | Pres. Mednax Natl Med Group | Form 4 sale | 11,607 | $524k | 26.1% | Unusual | SEC |
| Jun 1, 2017 | Jun 2, 2017 | MD | Pres. Mednax Natl Med Group | Form 4 sale | 10,202 | $561k | 28.9% | Unusual | SEC |
| Jun 1, 2016 | Jun 3, 2016 | MD | President, Western Division | Form 4 sale | 11,470 | $777k | 36.4% | Unusual | SEC |
| Jun 1, 2015 | Jun 3, 2015 | MD | COO, Pediatrix Medical Group | Form 4 sale | 14,654 | $1M | 40.5% | Unusual | SEC |
| Jun 2, 2014 | Jun 3, 2014 | MD | COO, Pediatrix Medical Group | Form 4 sale | 16,230 | $925k | 37.9% | Unusual | SEC |
| Jun 3, 2013 | Jun 4, 2013 | MD | COO, Pediatrix Medical Group | Form 4 sale | 8,645 | $787k | 35.2% | Unusual | SEC |
| Nov 23, 2012 | Nov 26, 2012 | MD | COO, Pediatrix Division | Form 4 sale | 2,019 | $156k | 10.3% | Plan not stated | SEC |
| Nov 20, 2012 | Nov 21, 2012 | MD | COO, Pediatrix Division | Form 4 sale | 600 | $46k | 3.3% | Plan not stated | SEC |
| Nov 7, 2012 | Nov 9, 2012 | MD | COO, Pediatrix Division | Form 4 sale | 9,881 | $762k | 35.9% | Unusual | SEC |
| Jun 1, 2012 | Jun 5, 2012 | MD | COO, Pediatrix Division | Form 4 sale | 9,152 | $548k | 34.1% | Unusual | SEC |
| Feb 27, 2012 | Feb 28, 2012 | MD | COO / Pediatrix Division | Form 4 sale | 13,800 | $1M | 44.5% | Unusual | SEC |
| Jun 2, 2011 | Jun 3, 2011 | MD | COO / Pediatrix Division | Form 4 sale | 8,188 | $603k | 32.2% | Unusual | SEC |
| May 20, 2011 | May 23, 2011 | MD | COO / Pediatrix Division | Form 4 sale | 1,200 | $91k | 6.4% | Plan not stated | SEC |
| Dec 10, 2010 | Dec 10, 2010 | MD | COO / Pediatrix Division | Form 4 sale | 7,456 | $483k | 29.8% | Unusual | SEC |
| Dec 2, 2010 | Dec 3, 2010 | MD | COO / Pediatrix Division | Form 4 sale | 2,960 | $192k | 14.4% | Plan not stated | SEC |
| Jun 1, 2010 | Jun 3, 2010 | MD | COO / Pediatrix Division | Form 4 sale | 6,755 | $378k | 42.7% | Unusual | SEC |
| Jun 1, 2009 | Jun 2, 2009 | MD | COO / Pediatrix Division | Form 4 sale | 4,792 | $194k | 50.4% | Unusual | SEC |